At Paragen, we are developing novel strategies for targeting promising new lead compounds in pharmaceutical drug discovery. We are adding to our database of new molecular entitles that have the potential to be among the next generation of pharmaceuticals. Our goal is to meet the needs of patients and physicians by facilitating the development of safer and more effective drugs in a variety of therapeutic areas.

 
Latest Company News
  (dec12 | 2006) Patent application entitled "Intellectual property related method and computer program" filed.

  (dec17 | 2007) Patent application entitled "UV-absorbing phenol ester compounds" filed.

  (jan 16 | 2008) Patent application entitled "Benzyl phenyl ether compounds" filed.

  (jun 04 | 2008) Patent application entitled "Phenyl amide compounds" filed.

  (jun 12 | 2008) Patent application entitled "Intellectual property related method and computer program" published as U.S. Patent Application No. 2008/0140695 A1.

Company Resources

Intellectual Property
Selection of patents pending from Paragen's portfolio.


Publications
Paragen makes research available to other scientists and to the public.

Research
New molecular entitles and pharmaceutical drug discovery.


Investor Relations
Information for current and prospective investors.

Visit our blog at http://blog.para-gen.com/.

Additional support files can be found at http://files.para-gen.com/.
Paragen, Inc.© 2008